Hem › Bukspottkörtelcancer › Texas › Dallas
Kliniska studier för Bukspottkörtelcancer i Dallas, TX
22 studier för Bukspottkörtelcancer söker deltagare vid platser i och runt Dallas (inom ca 30 miles). Öppna en studie för att se vem som kan delta och hur du kontaktar studieteamet.
Officiell studietext (engelska)
Rekryterar du till en studie? Visa den högst upp på sidan – $99 i 30 dagar →
DESTINY-PANTUMOUR04
RekryterarObservationsstudie
- Research Site, Dallas
A Study to Learn About the Medicine Ponsegromab in Adults With Cancer of the Pancreas Which Has Spread and Caused Significant Body Weight Loss and Fatigue
RekryterarFas 2/3
- University of Texas Southwestern Medical Center - Simmons Cancer Center, Dallas
- University of Texas Southwestern Medical Center-William P. Clements Jr. University Hospital, Dallas
- University of Texas Southwestern Medical Center-Zale Lipshy University Hospital, Dallas
- och 1 fler
Study of Daraxonrasib (RMC-6236) in Patients With Resected Pancreatic Ductal Adenocarcinoma (PDAC)
RekryterarFas 3
- Texas Oncology - DFW, Dallas
- University of Texas, Southwestern Medical Center, Dallas
A Study to Evaluate Chemotherapy With or Without INCB161734 in Previously Untreated, KRAS G12D-Mutated Metastatic Pancreatic Ductal Adenocarcinoma
RekryterarFas 3
- Investigative Site US067, Dallas
A Study to Evaluate the Effectiveness and Safety of Setidegrasib, Given With Either mFOLFIRINOX or NALIRIFOX Chemotherapies, in People With Pancreatic Cancer
RekryterarFas 3
- UT Southwestern Medical Center at Dallas, Dallas
Study of RMC-5127 in Patients With Advanced KRAS G12V-Mutant Solid Tumors
RekryterarFas 1
- NEXT - Dallas, Dallas
Biospecimen Collection to Identify Gene Mutations for High Risk Pancreatic Cancer in Pediatric Patients, INSPPIRE 2 Study
RekryterarObservationsstudie
- University of Texas Southwestern/Children's Medical Center, Dallas
Comparing the Clinical Impact of Pancreatic Cyst Surveillance Programs and Associated Biomarkers
RekryterarObservationsstudie
- UT Southwestern/Simmons Cancer Center-Dallas, Dallas
PTM-101 in Pancreatic Ductal Adenocarcinoma (PDAC)
RekryterarFas 1
- University of Texas Southwestern Medical Center, Dallas
Phase 1 Study of MRTX1719 in Solid Tumors With MTAP Deletion
RekryterarFas 1
- Ut Southwestern, Dallas
Testing Higher Dose Radiation Therapy for Locally Advanced Pancreatic Cancer
RekryterarFas 3
- Parkland Memorial Hospital, Dallas
- UT Southwestern Simmons Cancer Center - RedBird, Dallas
- UT Southwestern/Simmons Cancer Center-Dallas, Dallas
Extending Outcomes for Pancreas Cancer Patients With Nominal Oligometastatic Disease (EXPAND): A Randomized Phase III Trial
RekryterarFas 3
- University of Texas Southwestern Medical Center, Dallas
A Phase 2 Study of Zanidatamab in Patients With HER2-expressing Tumors
RekryterarFas 2
- Texas Oncology - DFW, Dallas
Study of RMC-9805 in Participants With KRAS G12D-Mutant Solid Tumors
RekryterarFas 1
- Sarah Cannon Research Institute at Mary Crowley, Dallas
Study of RMC-6236 in Patients With Advanced Solid Tumors Harboring Specific Mutations in RAS
RekryterarFas 1/2
- Mary Crowley Cancer Research, Dallas
Evaluation of Resection Techniques for Pancreatic Tumors
RekryterarObservationsstudie
- Methodist Dallas Medical Center, Dallas
Study of CP-383 in Patients With Advanced or Metastatic Solid Tumors
RekryterarFas 1/2
- NEXT Oncology - Dallas, Dallas
A Phase II Nationwide, Fully Decentralized, Telemedicine Study of Pemigatinib in Adult Patients With Advanced or Metastatic Pancreatic Cancer With FGFR Genetic Alterations
RekryterarFas 2
- Ohio State University-Telemedicine, Dallas
Phase 1/2a Study to Assess the Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of WEF-001 as Monotherapy in Advanced KRAS-Mutant Solid Tumours.
RekryterarFas 1/2
- NEXT Oncology Dallas, Dallas
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
RekryterarObservationsstudie
- Massive Bio SYNERGY-AI site, Dallas
A Study to Evaluate TROP2 ADC LCB84 Single Agent and in Combination With an Anti-PD-1 Ab in Advanced Solid Tumors
RekryterarFas 1/2
- Mary Crowley Cancer Research, Dallas
- University of Texas Southwestern Medical Center, Dallas
American Hepato-Pancreato-Biliary Association (AHPBA) Pancreatic Irreversible Electroporation (IRE) Registry
RekryterarObservationsstudie
- Methodist Digestive Institute, Dallas
Bukspottkörtelcancer-studier i andra städer
- Houston, TX61 studier
- New York City, NY60 studier
- Boston, MA43 studier
- Nashville, TN39 studier
- Los Angeles, CA35 studier
- St. Louis, MO33 studier
- Arlington, VA33 studier
- Baltimore, MD31 studier
- San Antonio, TX31 studier
- Philadelphia, PA26 studier
- Tampa, FL26 studier
- Durham, NC24 studier
Andra studier i Dallas
- Bröstcancer55 studier
- Icke-småcellig lungcancer52 studier
- Metastaserande cancer42 studier
- Hjärtsvikt42 studier
- Cancer (alla typer)37 studier
- Prostatacancer36 studier
- Kolorektal cancer33 studier
- Övervikt30 studier
- Äggstockscancer28 studier
- Lungcancer27 studier
- Blåscancer27 studier
- Endometriecancer24 studier
Från ClinicalTrials.gov, data hämtad 6 okt. 2026. Varje studie har egna kvalifikationskrav; studieteamet avgör vem som kan delta.